{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:51Z","timestamp":1794047451090,"version":"4.8.0"},"reference-count":47,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"8","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Juvenile myelomonocytic leukemia (JMML) is a rare, generally aggressive myeloproliferative neoplasm affecting young children. It is characterized by granulomonocytic expansion, with monocytosis infiltrating peripheral tissues. JMML is initiated by mutations upregulating RAS signaling. Approximately 10% of cases remain without an identified driver event. Exome sequencing of two unrelated cases of familial JMML of unknown genetics and analysis of the French JMML cohort identified 11 patients with variants in SH2B3, encoding LNK, a negative regulator of the JAK-STAT pathway. All variants were absent from healthy population databases, and the mutation spectrum was consistent with a loss of function of the LNK protein. A stoploss variant was shown to affect both protein synthesis and stability. The other variants were either truncating or missense, the latter affecting the SH2 domain that interacts with activated JAK. Of the 11 patients, eight from five families inherited pathogenic bi-allelic SH2B3 germline variants from their unaffected heterozygous parents. These children represent half of the cases with no identified causal mutation in the French cohort. They displayed typical clinical and hematologic features of JMML with neonatal onset and marked thrombocytopenia. They had a hypomethylated DNA profile with fetal characteristics and did not have additional genetic alterations. All patients showed partial or complete spontaneous clinical resolution. However, progression to thrombocythemia and immunity-related pathologies may be of concern later in life. Bi-allelic SH2B3 germline mutations thus define a new condition predisposing to a JMML-like disorder, suggesting that JAK pathway deregulation is capable of initiating JMML, and opening new therapeutic options.<\/jats:p>","DOI":"10.3324\/haematol.2023.283917","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T02:31:14Z","timestamp":1700101874000},"page":"2542-2554","source":"Crossref","is-referenced-by-count":9,"title":["Germline bi-allelic &lt;i&gt;SH2B3\/LNK&lt;\/i&gt; alteration predisposes to a neonatal juvenile myelomonocytic leukemia-like disorder"],"prefix":"10.3324","volume":"109","author":[{"given":"Chlo\u00e9","family":"Arfeuille","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Vial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Cadenet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Caye-Eude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Fenneteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline A","family":"Bonnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Carpentieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yline","family":"Capri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pedace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Macchiaiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Boudhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia ben","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wadih Abou","family":"Chahla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Lutun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mony","family":"Fahd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Drunat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Flex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Hugues","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Strullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tartaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Cav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"64444","doi-asserted-by":"crossref","unstructured":"Chang TY, Dvorak CC, Loh ML. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia. Blood. 2014; 124(16):2487-2497.","DOI":"10.1182\/blood-2014-03-300319"},{"key":"64445","doi-asserted-by":"crossref","unstructured":"Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015; 125(7):1083-1090.","DOI":"10.1182\/blood-2014-08-550483"},{"key":"64446","doi-asserted-by":"crossref","unstructured":"Locatelli F, N\u00f6llke P, Zecca M. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/ EBMT trial. Blood. 2005; 105(1):410-419.","DOI":"10.1182\/blood-2004-05-1944"},{"key":"64447","doi-asserted-by":"crossref","unstructured":"Lapidot T, Grunberger T, Vormoor J. Identification of human juvenile chronic myelogenous leukemia stem cells capable of initiating the disease in primary and secondary SCID mice. Blood. 1996; 88(7):2655-2664.","DOI":"10.1182\/blood.V88.7.2655.bloodjournal8872655"},{"key":"64448","doi-asserted-by":"crossref","unstructured":"Caye A, Rouault-Pierre K, Strullu M. Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment. Leukemia. 2020; 34(6):1658-1668.","DOI":"10.1038\/s41375-019-0662-y"},{"key":"64449","doi-asserted-by":"crossref","unstructured":"Louka E, Povinelli B, Rodriguez-Meira A. Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia. J Exp Med. 2021; 218(2):e20180853.","DOI":"10.1084\/jem.20180853"},{"key":"64450","doi-asserted-by":"crossref","unstructured":"Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood. 1991; 77(5):925-929.","DOI":"10.1182\/blood.V77.5.925.bloodjournal775925"},{"key":"64451","doi-asserted-by":"crossref","unstructured":"Lasho T, Patnaik MM. Juvenile myelomonocytic leukemia - a bona fide RASopathy syndrome. Best Pract Res Clin Haematol. 2020; 33(2):101171.","DOI":"10.1016\/j.beha.2020.101171"},{"key":"64452","doi-asserted-by":"crossref","unstructured":"Niemeyer CM. JMML genomics and decisions. Hematology. 2018; 2018(1):307-312.","DOI":"10.1182\/asheducation-2018.1.307"},{"key":"64453","doi-asserted-by":"crossref","unstructured":"Flex E, Jaiswal M, Pantaleoni F. Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis. Hum Mol Genet. 2014; 23(16):4315-4327.","DOI":"10.1093\/hmg\/ddu148"},{"key":"64454","doi-asserted-by":"crossref","unstructured":"Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: who\u2019s the driver at the wheel?. Blood. 2019; 133(10):1060-1070.","DOI":"10.1182\/blood-2018-11-844688"},{"key":"64455","doi-asserted-by":"crossref","unstructured":"Caye A, Strullu M, Guidez F. Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network. Nat Genet. 2015; 47(11):1334-1340.","DOI":"10.1038\/ng.3420"},{"key":"64456","doi-asserted-by":"crossref","unstructured":"Kratz CP, Niemeyer CM, Castleberry RP. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome\/myeloproliferative disease. Blood. 2005; 106(6):2183-2185.","DOI":"10.1182\/blood-2005-02-0531"},{"key":"64457","doi-asserted-by":"crossref","unstructured":"Tartaglia M, Niemeyer CM, Fragale A. Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet. 2003; 34(2):148-150.","DOI":"10.1038\/ng1156"},{"key":"64458","doi-asserted-by":"crossref","unstructured":"P\u00e9rez B, Mechinaud F, Galambrun C. Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. J Med Genet. 2010; 47(10):686-691.","DOI":"10.1136\/jmg.2010.076836"},{"key":"64459","doi-asserted-by":"crossref","unstructured":"Niemeyer CM. RAS diseases in children. Haematologica. 2014; 99(11):1653-1662.","DOI":"10.3324\/haematol.2014.114595"},{"key":"64460","doi-asserted-by":"crossref","unstructured":"Stieglitz E, Taylor-Weiner AN, Chang TY. The genomic landscape of juvenile myelomonocytic leukemia. Nat Genet. 2015; 47(11):1326-1333.","DOI":"10.1038\/ng.3400"},{"key":"64461","doi-asserted-by":"crossref","unstructured":"Oh ST, Simonds EF, Jones C. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood. 2010; 116(6):988-992.","DOI":"10.1182\/blood-2010-02-270108"},{"key":"64462","doi-asserted-by":"crossref","unstructured":"Takaki S, Morita H, Tezuka Y, Takatsu K. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med. 2002; 195(2):151-160.","DOI":"10.1084\/jem.20011170"},{"key":"64463","doi-asserted-by":"crossref","unstructured":"Bersenev A, Wu C, Balcerek J, Tong W. Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest. 2008; 118(8):2832-2844.","DOI":"10.1172\/JCI35808"},{"key":"64464","doi-asserted-by":"crossref","unstructured":"Morales CE, Stieglitz E, Kogan SC, Loh ML, Braun BS. Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia. Blood Adv. 2021; 5(18):3587-3591.","DOI":"10.1182\/bloodadvances.2020003754"},{"key":"64465","doi-asserted-by":"crossref","unstructured":"Bersenev A, Wu C, Balcerek J. Lnk constrains myeloproliferative diseases in mice. J Clin Invest. 2010; 120(6):2058-2069.","DOI":"10.1172\/JCI42032"},{"key":"64466","doi-asserted-by":"crossref","unstructured":"Oh ST. When the brakes are lost: LNK dysfunction in mice, men, and myeloproliferative neoplasms. Ther Adv Hematol. 2011; 2(1):11-19.","DOI":"10.1177\/2040620710393391"},{"key":"64467","doi-asserted-by":"crossref","unstructured":"Maslah N, Cassinat B, Verger E, Kiladjian J-J, Velazquez L. The role of LNK\/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders. Leukemia. 2017; 31(8):1661-1670.","DOI":"10.1038\/leu.2017.139"},{"key":"64468","doi-asserted-by":"crossref","unstructured":"Coltro G, Lasho TL, Finke CM. Germline SH2B3 pathogenic variant associated with myelodysplastic syndrome\/ myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. Am J Hematol. 2019; 94(9):E231-E234.","DOI":"10.1002\/ajh.25552"},{"key":"64469","doi-asserted-by":"crossref","unstructured":"McMullin MF, Wu C, Percy MJ, Tong W. A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis. Am J Hematol. 2011; 86(11):962-964.","DOI":"10.1002\/ajh.22154"},{"key":"64470","doi-asserted-by":"crossref","unstructured":"Spolverini A, Pieri L, Guglielmelli P. Infrequent occurrence of mutations in the PH domain of LNK in patients with JAK2 mutation-negative \u201cidiopathic\u201d erythrocytosis. Haematologica. 2013; 98(9):e101-102.","DOI":"10.3324\/haematol.2013.090175"},{"key":"64471","doi-asserted-by":"crossref","unstructured":"Perez-Garcia A, Ambesi-Impiombato A, Hadler M. Genetic loss of SH2B3 in acute lymphoblastic leukemia. Blood. 2013; 122(14):2425-2432.","DOI":"10.1182\/blood-2013-05-500850"},{"key":"64472","doi-asserted-by":"crossref","unstructured":"Blombery P, Pazhakh V, Albuquerque AS. Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi-organ autoimmunity. EJHaem. 2023; 4(2):463-469.","DOI":"10.1002\/jha2.698"},{"key":"64473","doi-asserted-by":"crossref","unstructured":"Arber DA, Orazi A, Hasserjian R. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016; 127(20):2391-2405.","DOI":"10.1182\/blood-2016-03-643544"},{"key":"64474","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022; 36(7):1703-1719.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"64475","doi-asserted-by":"crossref","unstructured":"Elghetany MT, Cav\u00e9 H, De Vito R, Patnaik MM, Solary E, Khoury JD. Juvenile myelomonocytic leukemia; moving forward. Leukemia. 2023; 37(3):720-722.","DOI":"10.1038\/s41375-023-01818-y"},{"key":"64476","doi-asserted-by":"crossref","unstructured":"Motta M, Pannone L, Pantaleoni F. Enhanced MAPK1 function causes a neurodevelopmental disorder within the RASopathy clinical spectrum. Am J Hum Genet. 2020; 107(3):499-513.","DOI":"10.1016\/j.ajhg.2020.06.018"},{"key":"64477","doi-asserted-by":"crossref","unstructured":"Rentzsch P, Schubach M, Shendure J, Kircher M. CADD-spliceimproving genome-wide variant effect prediction using deep learning-derived splice scores. Genome Med. 2021; 13(1):31.","DOI":"10.1186\/s13073-021-00835-9"},{"key":"64478","doi-asserted-by":"crossref","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V. REVEL: an Ensemble method for predicting the pathogenicity of rare missense variants. Am J Hum Genet. 2016; 99(4):877-885.","DOI":"10.1016\/j.ajhg.2016.08.016"},{"key":"64479","doi-asserted-by":"crossref","unstructured":"Morris R, Butler L, Perkins A, Kershaw NJ, Babon JJ. The role of LNK (SH2B3) in the regulation of JAK-STAT signalling in haematopoiesis. Pharmaceuticals (Basel). 2021; 15(1):24.","DOI":"10.3390\/ph15010024"},{"key":"64480","doi-asserted-by":"crossref","unstructured":"Sch\u00f6nung M, Meyer J, N\u00f6llke P. International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia. Clin Cancer Res. 2021; 27(1):158-168.","DOI":"10.1158\/1078-0432.CCR-20-3184"},{"key":"64481","doi-asserted-by":"crossref","unstructured":"Velazquez L, Cheng AM, Fleming HE. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med. 2002; 195(12):1599-1611.","DOI":"10.1084\/jem.20011883"},{"key":"64482","doi-asserted-by":"crossref","unstructured":"Nakamura-Ishizu A, Suda T. Multifaceted roles of thrombopoietin in hematopoietic stem cell regulation. Ann N Y Acad Sci. 2020; 1466(1):51-58.","DOI":"10.1111\/nyas.14169"},{"key":"64483","doi-asserted-by":"crossref","unstructured":"Buza-Vidas N, Antonchuk J, Qian H. Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev. 2006; 20(15):2018-2023.","DOI":"10.1101\/gad.385606"},{"key":"64484","doi-asserted-by":"crossref","unstructured":"Pietras EM, Passegu\u00e9 E. Linking HSCs to their youth. Nat Cell Biol. 2013; 15(8):885-887.","DOI":"10.1038\/ncb2817"},{"key":"64485","doi-asserted-by":"crossref","unstructured":"Helsmoortel HH, Bresolin S, Lammens T. LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia. Blood. 2016; 127(9):1163-1172.","DOI":"10.1182\/blood-2015-09-667808"},{"key":"64486","doi-asserted-by":"crossref","unstructured":"Bader-Meunier B, Cav\u00e9 H, Jeremiah N. Are RASopathies new monogenic predisposing conditions to the development of systemic lupus erythematosus? Case report and systematic review of the literature. Semin Arthritis Rheum. 2013; 43(2):217-219.","DOI":"10.1016\/j.semarthrit.2013.04.009"},{"key":"64487","doi-asserted-by":"crossref","unstructured":"Lv K, Jiang J, Donaghy R. CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies. Genes Dev. 2017; 31(10):1007-1023.","DOI":"10.1101\/gad.297135.117"},{"key":"64488","doi-asserted-by":"crossref","unstructured":"Ren J-G, Xing B, Lv K. RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia. J Clin Invest. 2023; 133(12):e165510.","DOI":"10.1172\/JCI165510"},{"key":"64489","doi-asserted-by":"crossref","unstructured":"Kotecha N, Flores NJ, Irish JM. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell. 2008; 14(4):335-343.","DOI":"10.1016\/j.ccr.2008.08.014"},{"key":"64490","doi-asserted-by":"crossref","unstructured":"Strullu M, Caye A, Lachenaud J. Juvenile myelomonocytic leukaemia and Noonan syndrome. J Med Genet. 2014; 51(10):689-697.","DOI":"10.1136\/jmedgenet-2014-102611"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283917\/76289","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.283917\/77346","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11345\/76289","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:05:14Z","timestamp":1794045914000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.283917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.283917","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}